Alpha Tau Medical Ltd. | Micro-cap | Healthcare
$3.00
1.01%
| Alpha Tau Medical Stock Comparison:
Alpha Tau Medical vs VertexAlpha Tau Medical vs RegeneronAlpha Tau Medical vs CartesianAlpha Tau Medical vs Foghorn TherapeuticsAlpha Tau Medical vs Tevogen Bio HoldingsAlpha Tau Medical vs S&P 500 | Market
Overview Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

Financial Overview

Latest Annual: 2024

Income Metrics

Revenue 0
Operating Income -36.0M
Net Income -31.8M

Balance Sheet Metrics

Total Assets 86.2M
Total Liabilities 23.5M
Shareholders Equity 62.7M
Debt to Equity 0.38

Cash Flow Metrics

Operating Cash Flow -19.7M
Free Cash Flow -22.0M

Revenue & Profitability Trend

Alpha Tau Medical Income Statement From 2020 to 2024

Metric 2024 2023 2022 2021 2020
Revenue 0 0 0 0 0
Cost of Goods Sold - - - - -
Gross Profit - - - - -
Operating Expenses 36.0M 35.7M 32.1M 13.8M 9.2M
Operating Income -36.0M -35.7M -32.1M -13.8M -9.2M
Pre-tax Income -31.7M -29.1M -33.7M -27.3M -8.7M
Income Tax 6.0K 16.0K 20.0K 7.0K 158.0K
Net Income -31.8M -29.2M -33.8M -27.3M -8.9M
EPS (Diluted) - -$0.42 -$0.53 -$0.40 -$0.13

Income Statement Trend

Alpha Tau Medical Balance Sheet From 2020 to 2024

Metric 2024 2023 2022 2021 2020
Assets
Current Assets 64.2M 85.8M 106.5M 32.6M 47.5M
Non-Current Assets 22.0M 21.6M 13.7M 9.6M 5.5M
Total Assets 86.2M 107.4M 120.1M 42.2M 53.0M
Liabilities
Current Liabilities 8.7M 7.1M 4.3M 4.4M 2.1M
Non-Current Liabilities 14.9M 15.8M 10.2M 72.6M 59.3M
Total Liabilities 23.5M 22.9M 14.5M 77.0M 61.4M
Equity
Total Shareholders Equity 62.7M 84.5M 105.7M -34.8M -8.4M

Balance Sheet Composition

Alpha Tau Medical Cash Flow Statement From 2020 to 2024

Metric 2024 2023 2022 2021 2020
Operating Activities
Net Income -31.8M -29.2M -33.8M -27.3M -8.9M
Operating Cash Flow -19.7M -17.4M -27.8M -25.4M -8.2M
Investing Activities
Capital Expenditures -2.2M -6.4M -904.0K -2.9M -3.8M
Investing Cash Flow 20.8M 18.7M -89.9M 19.3M -7.8M
Financing Activities
Dividends Paid - - - - -
Financing Cash Flow 0 5.2M 93.5M 0 28.7M
Free Cash Flow -22.0M -24.4M -24.8M -14.7M -11.0M

Cash Flow Trend

Alpha Tau Medical Key Financial Ratios

Valuation Ratios

Forward P/E -5.92
Price to Book 3.63
PEG Ratio -5.92

Profitability Ratios

Profit Margin 0.00%
Operating Margin 0.00%
Return on Equity -47.95%
Return on Assets -25.17%

Financial Health

Current Ratio 5.82
Debt to Equity 21.83
Beta 0.99

Per Share Data

EPS (TTM) -$0.46
Book Value per Share $0.80

Peer Financial Comparison

Company Market Cap P/E Ratio P/B Ratio ROE Profit Margin Debt/Equity
drts 245.6M - 3.63 -47.95% 0.00% 21.83
Vertex 114.1B 32.82 6.92 -5.64% -8.91% 10.00
Regeneron 55.3B 13.02 1.84 15.96% 31.94% 9.20
Cartesian 250.0M 1.81 -12.32 1,138.25% -112.11% -0.65
Foghorn Therapeutics 272.6M - -5.07 190.26% 0.00% -0.57
Tevogen Bio Holdings 222.5M 2.86 -24.67 205.68% 0.00% -0.62

Financial data is updated regularly. All figures are in the company's reporting currency.